{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:17:26Z","timestamp":1768339046312,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ahj.2022.01.015","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T11:57:00Z","timestamp":1644235020000},"page":"76-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-8330","authenticated-orcid":false,"given":"Abhinav","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Elharram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-4937","authenticated-orcid":false,"given":"Jonathan","family":"Afilalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Afilalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Tselios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-8170","authenticated-orcid":false,"given":"Jiayi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8049-6875","authenticated-orcid":false,"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Bessissow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Kronfli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5081-7356","authenticated-orcid":false,"given":"Haya","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-1635","authenticated-orcid":false,"given":"Mohammad","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Aflaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4770","authenticated-orcid":false,"given":"Morgan","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2022.01.015_bib0001","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2022.01.015_bib0002","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2022.01.015_bib0003","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2022.01.015_bib0004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ehjqcco\/qcaa081","article-title":"Cardiovascular comorbidities as predictors for severe COVID-19 infection or death","volume":"7","author":"Phelps","year":"2021","journal-title":"Eur Hear J - Qual Care Clin Outcomes"},{"key":"10.1016\/j.ahj.2022.01.015_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41371-020-0387-4","article-title":"Covid-19 and the cardiovascular system: a comprehensive review","volume":"35","author":"Azevedo","year":"2020","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ahj.2022.01.015_bib0006","first-page":"4","article-title":"Approach to acute cardiovascular complications in COVID-19 infection","volume":"13","author":"Ranard","year":"2020","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.ahj.2022.01.015_bib0007","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/eurheartj\/ehab075","article-title":"Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance","volume":"42","author":"Kotecha","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ahj.2022.01.015_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/CIRCULATIONAHA.121.054969","article-title":"Prognostic value of natriuretic peptides and cardiac troponins in COVID-19","volume":"144","author":"Cunningham","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.01.015_bib0009","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2022.01.015_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ahj.2022.01.015_bib0011","first-page":"43","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharm J Pharm Educ Pract."},{"key":"10.1016\/j.ahj.2022.01.015_bib0012","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA - J Am Med Assoc."},{"key":"10.1016\/j.ahj.2022.01.015_bib0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin\u2013angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.ahj.2022.01.015_bib0014","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.ahj.2022.01.015_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J Card Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0016","unstructured":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang [accessed 29 March 2021]."},{"key":"10.1016\/j.ahj.2022.01.015_bib0017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ehjcvp\/pvaa064","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"7","author":"Grover","year":"2021","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2022.01.015_bib0018","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13063-021-05080-4","article-title":"Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): a structured summary of a study protocol for a randomized controlled trial","volume":"22","author":"Aflaki","year":"2021","journal-title":"Trials"},{"issue":"3-6","key":"10.1016\/j.ahj.2022.01.015_bib0019","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and prevention","volume":"2019","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.01.015_bib0020","first-page":"19","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"19","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2022.01.015_bib0021","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ahj.2022.01.015_bib0022","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jchf.2020.03.005","article-title":"Heart failure collaboratory statement on clinical trials in the landscape of COVID-19","volume":"8","author":"Abraham","year":"2020","journal-title":"JACC Hear Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0023","first-page":"123","article-title":"Comparison of outcome adjudication by investigators and by a central end point committee in heart failure trials","volume":"13","author":"Tyl","year":"2020","journal-title":"Circ Hear Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0024","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ahj.2010.07.004","article-title":"Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (\u03b2-Blocker Evaluation of Survival Trial [BEST])","volume":"160","author":"Carson","year":"2010","journal-title":"Am Heart J."},{"key":"10.1016\/j.ahj.2022.01.015_bib0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.01.015_bib0026","first-page":"2019","article-title":"Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State","volume":"4720","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.01.015_bib0027","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCHEARTFAILURE.109.926030","article-title":"A global rank end point for clinical trials in acute heart failure","volume":"3","author":"Felker","year":"2010","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0028","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCHEARTFAILURE.112.969154","article-title":"Evaluating treatment efficacy by multiple end points in phase ii acute heart failure clinical trials analyzing data using a global method","volume":"5","author":"Sun","year":"2012","journal-title":"Circ Hear Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0029","doi-asserted-by":"crossref","first-page":"23670","DOI":"10.1038\/s41598-021-03244-5","article-title":"The effect of renin-angiotensin-aldosterone system inhibitors on organ-specific ace2 expression in zebrafish and its implications for COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.ahj.2022.01.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2021.06.013","article-title":"Prescription filling patterns of evidence-based medical therapies for heart failure during the COVID-19 pandemic in the United States","author":"Vaduganathan","year":"2021","journal-title":"J Card Fail."},{"key":"10.1016\/j.ahj.2022.01.015_bib0031","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2022.01.015_bib0032","doi-asserted-by":"crossref","unstructured":"Mancia G, Rea F, Ludergnani M, et\u00a0al. Renin\u2013Angiotensin\u2013Aldosterone system blockers and the risk of Covid-19. 2020;382:2431-2440. doi:10.1056\/NEJMOA2006923.","DOI":"10.1056\/NEJMoa2006923"},{"key":"10.1016\/j.ahj.2022.01.015_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021154","article-title":"Renin-Angiotensin Aldosterone system inhibitors in primary prevention and COVID-19","volume":"10","author":"Loader","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.ahj.2022.01.015_bib0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ahj.2021.06.004","article-title":"Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system","volume":"240","author":"Sandhu","year":"2021","journal-title":"Am Heart J."},{"key":"10.1016\/j.ahj.2022.01.015_bib0035","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.2020.17445","article-title":"COVID-19 and heart failure with preserved ejection fraction","volume":"324","author":"Freaney","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.ahj.2022.01.015_bib0036","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week","volume":"76","author":"Sandoval","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.01.015_bib0037","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.120.047971","article-title":"Spectrum of cardiac manifestations in COVID-19","volume":"142","author":"Szekely","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.01.015_bib0038","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2022.01.015_bib0039","unstructured":"Krahn A. COVID-19 and Concerns Regarding Use of ACEi\/ARB\/ARNi Medications for Heart Failure or Hypertension. https:\/\/www.acc.org\/latest-in-cardiology\/features\/accs-coronavirus-disease-2019- [accessed 28 March 2021]."},{"key":"10.1016\/j.ahj.2022.01.015_bib0040","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:08:18Z","timestamp":1757570898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":40,"alternative-id":["S0002870322000242"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.01.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}